Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr Amrik Basran gained his PhD in biochemistry (University of Leicester, 1996) and spent 6 years as a post-doctoral researcher at the Institute of Biotechnology (Cambridge University) isolating novel bacterial pathways involved with the metabolism of illicit drugs and high explosives. In 2002, Amrik joined Domantis, (Cambridge, UK) developing human domain antibodies. In 2006, GSK acquired Domantis, after which he became Head of Topical Delivery, supporting the development of biotherapeutics for delivery into the eye, skin, lung and gut. Amrik left GSK in 2012 and joined Avacta in 2013 as Chief Scientific Officer to develop the Affimer platform for therapeutic use, focusing on immuno-oncology.